Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 3, 2011

View Archived Issues

Summit presents preclinical data on antimicrobial agents targeting CDI

Final first-in-human data presented on CureVac's prostate cancer mRNA vaccine

Horizon Pharma submits NDA for Lodotra to FDA

BioDelivery Sciences reports preliminary data from BEMA Buprenorphine trial

Canadian university discloses novel Abeta-targeted antibodies

Amira Pharmaceuticals patents new 5-LO inhibitors

Advanced Cell Technology receives approval to treat more patients in two U.S. stem cell trials

Scientists identify SNP associated with increased susceptibility to bacterial meningitis

Bacterial DNA minor groove binder shows promise against CDI-associated diarrhea

Eisai evaluates new anticoagulants in human microdosing study

Japanese Pharmaceutical Affairs Subcommittee reviews Chugai's application for Epogin

Dosing begins in Trius' phase III TR701-113 trial

FDA reviews safety of drospirenone-containing birth control pills

Novel anticancer derivatives presented

Boehringer Ingelheim Pharma claims new therapeutics targeting amyloid beta

GlaxoSmithKline reports new SAP-binding proteins

Pharmaxis completes enrollment in phase II ASM-8 trial

Durata Therapeutics begins enrollment in second pivotal dalbavancin trial

Children's Oncology Group and Apeiron to collaborate on phase II study in neuroblastoma

Proteonomix continues preparations for clinical trial of stem cell treatment for ESLD

Almirall launches Libertek in Spain

Microbicide Trials Network to discontinue use of tenofovir tablets in HIV prevention study

Baxter files MAA with EMA for investigational Ig therapy

Formal Medicare coverage policy established for Genomic Health's Oncotype DX colon cancer test

Takeda completes Nycomed acquisition

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...